NEW YORK - Reed Smith recently advised EW Healthcare Partners in its role as a financial sponsor to Cognate BioServices, Inc. in support of its short-term and long-term growth. The firm previously advised EW on its lead investment in the Series C Preferred Stock Round of Tissue Tech, Inc.
Cognate is a leading contract development and manufacturing organization in the nascent cellular therapy industry and is backed by Blackrock among other investors. Founded in 1985, EW Healthcare is one of the largest and oldest growth equity firms pursuing investments in pharmaceuticals, medical devices, healthcare services and healthcare information technology with over $3 billion in funds raised. This is the second investment by EW Healthcare from its latest PE fund. The completion of this investment represents yet another milestone in the successful relationship between Reed Smith and EW Healthcare.